Maureen Lundt

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease”.

A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease

Blood(2022)10.1182/blood.2022015403

N/A

2.4DataRank · unranked

74 citations

Anna Conrey, Ingrid Frey, Eveline Gwaabe, Laurel A. Menapace, Laxminath Tumburu +15 more

Functional and multi-omics signatures of mitapivat efficacy upon activation of pyruvate kinase in red blood cells from patients with sickle cell disease

Haematologica(2024)10.3324/haematol.2023.284831

N/A

0.538DataRank · unranked

12 citations

Kang Le, Maureen Lundt, Quan Li, Emily B. Dunkelberger, Troy Cellmer +9 more

Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylation

Blood Advances(2024)10.1182/bloodadvances.2024013504

N/A

0.461DataRank · unranked

15 citations

Xunde Wang, Jonathan M. Chu, Maureen Lundt, Yuan Yee Lee, Anna Conrey +9 more